Effectiveness of 1, 2, and 3 Doses of HPV Vaccine Effectiveness of 1, 2, and 3 Doses of HPV Vaccine

This study evaluated the real-world vaccine effectiveness of 1, 2, or 3 doses of HPV vaccine against the development of high-grade cervical lesions.American Journal of Epidemiology
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Ob/Gyn & Women ' s Health Journal Article Source Type: news

Related Links:

The World Health Organization (WHO) has released a preliminary framework for the global allocation of COVID-19 vaccines when they become available. The plan is intended to guide policymakers at the global, regional, and national level in their allocation and prioritization decisions about vaccines. WHO’s “fair allocation mechanism” emphasizes equitable allocation of vaccines and lists groups of people that should have priority access. The plan proposes vaccine distribution in two phases. In the first phase, all countries would receive vaccine doses in proportion to their population size - initially enoug...
Source: Public Policy Reports - Category: Biology Authors: Source Type: news
There is a small chance that Pfizer's vaccine trial will yield results by Nov. 3. Here's everything that has to happen and how to tell a political stunt from a real vaccine.ProPublica
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Public Health & Prevention News Source Type: news
Health workers and the elderly should be prioritized in case of any shortages, the World Health Organization (WHO) said on Friday.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
Johnson&Johnson has signed a manufacturing deal for its coronavirus vaccine candidate with Grand River Aseptic Manufacturing Inc, the contract manufacturing organization said on Friday.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
The global death toll from COVID-19 could double to 2 million before a successful vaccine is widely used and could be even higher without concerted action to curb the pandemic, a WHO official said on Friday.Reuters Health Information
Source: Medscape Critical Care Headlines - Category: Intensive Care Tags: Infectious Diseases News Source Type: news
Condition:   Chikungunya Interventions:   Drug: BBV87 Chikungunya vaccine;   Drug: Normal Saline Sponsor:   International Vaccine Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   COVID-19 Vaccine;   Safety Issues Intervention:   Biological: ChulaCov19 mRNA vaccine Sponsors:   Chulalongkorn University;   Center of Excellence in Vaccine Research and Development, Chulalongkorn University;   Center of Excellence for Vaccine Trial (Vaccine Trial Centre), Faculty of Tropical Medicine, Mahidol University;   Chula Clinical Research Center (ChulaCRC), Faculty of Medicine, Chulalongkorn University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Conditions:   Preventable Disease, Vaccine;   Health Care Utilization Interventions:   Other: 1 automated message;   Other: 2 automated messages;   Other: No personal contact attempt;   Other: 1 personal contact attempt Sponsor:   Children's Hospital Medical Center, Cincinnati Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   Gastric Cancer Interventions:   Biological: DC vaccine;   Biological: CTL;   Drug: Sintilimab Injection Sponsors:   The Second Hospital of Shandong University;   Shandong Sunstem Biotechnology Co.,Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
Condition:   COVID-19 Interventions:   Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector);   Biological: Recombinant Novel Coronavirus Vaccine (Adenovirus Type 5 Vector) -placebo Sponsors:   CanSino Biologics Inc.;   Beijing Institute of Biotechnology;   Jiangsu Province Centers for Disease Control and Prevention Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Epidemiology | Health | Study | Vaccines | Women